Jul 30, 2020
Trial data support dexamethasone, but not hydroxychloroquine, for COVID-19
Posted by Nicholi Avery in category: biotech/medical
According to the University of Minnesota trial data supports dexamethasone over Hydroxychloroquine:
Data from a large randomized controlled trial in the United Kingdom showing a benefit from use of the steroid dexamethasone in hospitalized COVID-19 patients was released today in the New England Journal of Medicine (NEJM), while two more studies show no benefit for the malaria drug hydroxychloroquine.
The NEJM data, which were originally reported in a press release in mid-June by the chief investigators of the RECOVERY (Randomized Evaluation of COVID-19 Therapy) trial after an interim analysis, show that in patients needing mechanical ventilation, dexamethasone reduced deaths by 36% compared with usual care. In patients receiving oxygen, the incidence of death was 18% lower for patients on dexamethasone.
Continue reading “Trial data support dexamethasone, but not hydroxychloroquine, for COVID-19” »